Clinical trial
Neurocognitive Testing in Long COVID and Postural Tachycardia Syndrome Patients With Normal Saline: A Pilot Study
NCT05914649 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurocognitive Testing in Long COVID and Postural Tachycardia Syndrome Patients With Normal Saline: A Pilot Study
- Lead sponsor
- University of Calgary
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 19, 2024
- Completion date
- December 31, 2030
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
post acute sequelae of sars cov 2 infection, postural orthostatic tachycardia syndrome